Wockhardt Limited has informed the Exchange regarding a press release dated May 29, 2026, titled " Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis.
Press Release May 30 2026
Earlier from Wockhardt
- Press Release May 28 2026
- Press Release May 04 2026
- Press Release Mar 30 2026
- Press Release Feb 10 2026